Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy

X Meng, Z Lu, Q Lv, Y Jiang, L Zhang, Z Wang - Acta biomaterialia, 2022 - Elsevier
Cancer cells rely on glycolysis to support a high proliferation rate. Metformin (Met) is a
promising drug for tumor treatment that targets hexokinase 2 (HK2) to block the glycolytic …
被引用次数：35 相关文章

Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy.

X Meng, Z Lu, Q Lv, Y Jiang, L Zhang, Z Wang - Acta Biomaterialia, 2022 - europepmc.org
Cancer cells rely on glycolysis to support a high proliferation rate. Metformin (Met) is a
promising drug for tumor treatment that targets hexokinase 2 (HK2) to block the glycolytic …

Tumor Metabolism Destruction Via Metformin-Based Glycolysis Inhibition and Glucose Oxidase-Mediated Glucose Deprivation for Enhanced Cancer Therapy

X Meng, Z Lu, Q Lv, Y Jiang, L Zhang… - Available at SSRN … - papers.ssrn.com
Cancer cells rely on glycolysis to support a high proliferation rate. Metformin (Met) is a
promising drug for tumor treatment that targets hexokinase 2 (HK2) to block the glycolytic …

Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy

X Meng, Z Lu, Q Lv, Y Jiang, L Zhang… - Acta …, 2022 - pubmed.ncbi.nlm.nih.gov
Cancer cells rely on glycolysis to support a high proliferation rate. Metformin (Met) is a
promising drug for tumor treatment that targets hexokinase 2 (HK2) to block the glycolytic …